Tracon: Q4 Earnings Snapshot
In this article:
SAN DIEGO (AP) — SAN DIEGO (AP) — Tracon Pharmaceuticals Inc. (TCON) on Tuesday reported earnings of $439,000 in its fourth quarter.
On a per-share basis, the San Diego-based company said it had net income of 1 cent.
The antibody drug developer posted revenue of $3.4 million in the period.
For the year, the company reported a loss of $3.6 million, or 11 cents per share. Revenue was reported as $12 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCON at https://www.zacks.com/ap/TCON
